|
||||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
|
||||||||||||||||||||
| ||||||||||||||||||||
1 | AN ACT concerning optometry.
| |||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||
3 | represented in the General Assembly:
| |||||||||||||||||||
4 | Section 5. The Illinois Optometric Practice Act of 1987 is | |||||||||||||||||||
5 | amended by
changing Section 15.1 as follows:
| |||||||||||||||||||
6 | (225 ILCS 80/15.1)
| |||||||||||||||||||
7 | (Section scheduled to be repealed on January 1, 2007)
| |||||||||||||||||||
8 | Sec. 15.1. Diagnostic and therapeutic certification.
| |||||||||||||||||||
9 | (a) Any licensed optometrist may apply to the Department, | |||||||||||||||||||
10 | in the form the
Department may prescribe, for a certificate to | |||||||||||||||||||
11 | use diagnostic topical ocular
pharmaceutical agents and the | |||||||||||||||||||
12 | Department shall certify the
applicant if:
| |||||||||||||||||||
13 | (1) the applicant has received appropriate training | |||||||||||||||||||
14 | and certification from
a properly accredited institution | |||||||||||||||||||
15 | of higher learning for the certificate; and
| |||||||||||||||||||
16 | (2) the applicant has demonstrated training and | |||||||||||||||||||
17 | competence to use
diagnostic topical ocular pharmaceutical | |||||||||||||||||||
18 | agents as required by the
Board pursuant to rule or | |||||||||||||||||||
19 | regulation approved by the
Board and adopted
by the | |||||||||||||||||||
20 | Department.
| |||||||||||||||||||
21 | A certificate to use topical ocular pharmaceutical agents | |||||||||||||||||||
22 | for diagnostic
purposes previously issued
by the Department | |||||||||||||||||||
23 | that is current and valid on the effective date of this
| |||||||||||||||||||
24 | amendatory Act of 1995 is valid until its expiration date and | |||||||||||||||||||
25 | entitles the
holder of the certificate to use diagnostic | |||||||||||||||||||
26 | topical ocular pharmaceutical
agents as provided in this Act.
| |||||||||||||||||||
27 | (b) Any licensed optometrist may apply to the Department, | |||||||||||||||||||
28 | in the form the
Department may prescribe, for a certificate to | |||||||||||||||||||
29 | use therapeutic ocular
pharmaceutical agents and the | |||||||||||||||||||
30 | Department shall certify the applicant if:
| |||||||||||||||||||
31 | (1) the applicant has received a certificate to use | |||||||||||||||||||
32 | diagnostic topical
ocular pharmaceutical agents under |
| |||||||
|
|||||||
1 | subsection (a);
| ||||||
2 | (2) the applicant has received appropriate training | ||||||
3 | and certification from
a properly accredited institution | ||||||
4 | of higher learning for the certificate; and
| ||||||
5 | (3) the applicant has demonstrated training and | ||||||
6 | competence to use
therapeutic ocular pharmaceutical agents | ||||||
7 | as required by the Board pursuant
to rule or regulation | ||||||
8 | approved by the Board and adopted by
the Department.
| ||||||
9 | All applicants for license renewal after January 1, 2030
| ||||||
10 | 2006 must
apply for and maintain certification to use | ||||||
11 | therapeutic ocular pharmaceutical
agents.
| ||||||
12 | (c) For purposes of the Act, "diagnostic topical ocular | ||||||
13 | pharmaceutical
agents" means anesthetics, mydriatics, | ||||||
14 | cycloplegics, and miotics used for
diagnostic purposes as | ||||||
15 | defined by the Board pursuant to rule
approved
by the Board and | ||||||
16 | adopted by the Department.
| ||||||
17 | (d) For the purposes of the Act, "therapeutic ocular | ||||||
18 | pharmaceutical agents"
means the following when used for | ||||||
19 | diagnostic or therapeutic purposes:
topical
anti-infective | ||||||
20 | agents,
topical anti-allergy agents,
topical
anti-glaucoma | ||||||
21 | agents, topical anti-inflammatory agents, topical
anesthetic
| ||||||
22 | agents, over the counter agents, non-narcotic oral analgesic
| ||||||
23 | agents,
and mydriatic reversing
agents.
| ||||||
24 | (e) A licensed optometrist who is therapeutically | ||||||
25 | certified may remove
superficial foreign bodies from the human | ||||||
26 | eye and adnexa.
| ||||||
27 | (e-5) A licensed optometrist who is therapeutically
| ||||||
28 | certified may give orders for patient care related to the use | ||||||
29 | of
therapeutic ocular pharmaceutical agents to a nurse licensed | ||||||
30 | to practice under
Illinois law.
| ||||||
31 | (f) An optometrist's certificate to use diagnostic topical | ||||||
32 | ocular
pharmaceutical agents shall be revoked or suspended by | ||||||
33 | the Department upon
recommendation of the Board based on the | ||||||
34 | misuse of any
diagnostic topical
ocular pharmaceutical agent.
| ||||||
35 | (g) An optometrist's certificate to use therapeutic ocular
| ||||||
36 | pharmaceutical agents shall be revoked or suspended by
the |
| |||||||
|
|||||||
1 | Department upon recommendation of the Board based on the
misuse | ||||||
2 | of any
therapeutic ocular pharmaceutical agent.
| ||||||
3 | (h) An optometrist's license shall be revoked or suspended | ||||||
4 | by the Department
upon recommendation of the Board based upon | ||||||
5 | either of the
following causes:
| ||||||
6 | (1) grave or repeated misuse of any diagnostic or | ||||||
7 | therapeutic ocular
pharmaceutical agent; and
| ||||||
8 | (2) the use of any agent or procedure in the course of | ||||||
9 | optometric practice
by an optometrist not properly | ||||||
10 | certified under this Section.
| ||||||
11 | (i) The provisions of Sections 26.2, 26.3, 26.5, 26.10, | ||||||
12 | 26.11, 26.14, and
26.15 of this Act shall apply to all | ||||||
13 | disciplinary proceedings brought under
this Section.
| ||||||
14 | (j) The Director may temporarily suspend a certificate to | ||||||
15 | use diagnostic
topical ocular pharmaceuticals or a certificate | ||||||
16 | to use
therapeutic ocular pharmaceuticals or a license to | ||||||
17 | practice optometry, without
a hearing, simultaneously with the | ||||||
18 | institution of proceedings for a hearing
based upon a violation | ||||||
19 | of subsection (f), (g), or (h) of this Section, if the
Director | ||||||
20 | finds that evidence in his or her possession indicates that the
| ||||||
21 | continued use of diagnostic topical ocular pharmaceuticals, or
| ||||||
22 | therapeutic ocular pharmaceuticals, or continued practice of | ||||||
23 | optometry would
constitute an immediate danger to the public. | ||||||
24 | In the event that the Director
temporarily suspends a | ||||||
25 | certificate to use diagnostic topical ocular
pharmaceuticals, | ||||||
26 | therapeutic ocular pharmaceuticals, or a
license to practice | ||||||
27 | optometry without a hearing, a hearing by the Board
shall be | ||||||
28 | commenced within 15 days after suspension has occurred, and | ||||||
29 | concluded
without appreciable delay.
| ||||||
30 | (k) The Director of the Department of Professional | ||||||
31 | Regulation shall notify
the Director of the Department of | ||||||
32 | Public Health as to the categories of ocular
pharmaceutical | ||||||
33 | agents permitted for use by an optometrist. The Director of the
| ||||||
34 | Department of Public Health shall in turn
notify every licensed | ||||||
35 | pharmacist in the State of the categories of ocular
| ||||||
36 | pharmaceutical agents that can be utilized and prescribed by an |
| |||||||
|
|||||||
1 | optometrist.
| ||||||
2 | (l) Nothing in this Act prohibits the use of diagnostic
| ||||||
3 | topical ocular pharmaceutical agents or therapeutic ocular | ||||||
4 | pharmaceutical
agents
in the practice of optometry by | ||||||
5 | optometrists certified for such use under this
Section.
| ||||||
6 | (Source: P.A. 90-73, eff. 7-8-97; 91-141, eff. 7-16-99.)
| ||||||
7 | Section 99. Effective date. This Act takes effect upon | ||||||
8 | becoming law. |